Salt water as fuel? Erie man hopes so. For obvious reasons, scientists long have thought that salt water couldn't be burned. So when an Erie man announced he'd ignited salt water with the radio-frequency generator he'd invented, some thought it a was a hoax. John Kanzius, a Washington County native, tried to desalinate seawater with a generator he developed to treat cancer, and it caused a flash in the test tube. Within days, he had the salt water in the test tube burning like a candle, as long as it was exposed to radio frequencies. His discovery has spawned scientific interest in using the world's most abundant substance as clean fuel, among other uses. Rustum Roy, a Penn State University chemist, held a demonstration last week at the university's Materials Research Laboratory in State College, to confirm what he'd witnessed weeks before in an Erie lab.
"It's true, it works," Dr. But there are no electrodes and no gimmicks, he said. Dr. As such, Dr. But researching its potential will take time and money, he said. Dr. Mr. Mr. Salt Water Fuel and a Cancer Cure by accident. John Kanzius. This article is about the inventor. For the 15th century theologian, see John Cantius. John S. Kanzius (March 1, 1944 – February 18, 2009) was an American inventor, radio and TV engineer, one-time station owner and ham radio operator (Call Sign K3TUP) from Erie, Pennsylvania. He invented a method that, he said, could treat virtually all forms of cancer,[1] with no side effects, and without the need for surgery or medication.[1][2][3][needs update] He also demonstrated a device that generated flammable hydrogen-containing gas from salt-water-solution by the use of radiowaves.
In the media this was dubbed "burning salt water". Both effects involve the use of his radio frequency transmitter. Cancer therapy[edit] Kanzius RF Therapy is an experimental cancer treatment that employs a combination of either gold or carbon nanoparticles and radio waves.[2][6][7] The specific absorption rate for radio waves by living tissue in the proposed wavelengths and intensity levels is very low. See also[edit]
Kanzius RF Therapy. This article is about the inventor. For the 15th century theologian, see John Cantius. John S. Kanzius (March 1, 1944 – February 18, 2009) was an American inventor, radio and TV engineer, one-time station owner and ham radio operator (Call Sign K3TUP) from Erie, Pennsylvania. He invented a method that, he said, could treat virtually all forms of cancer,[1] with no side effects, and without the need for surgery or medication.[1][2][3][needs update] He also demonstrated a device that generated flammable hydrogen-containing gas from salt-water-solution by the use of radiowaves. In the media this was dubbed "burning salt water". Both effects involve the use of his radio frequency transmitter.
Cancer therapy[edit] Kanzius RF Therapy is an experimental cancer therapy that employs a combination of either gold or carbon nanoparticles and radio waves.[2][6][7] The specific absorption rate for radio waves by living tissue in the proposed wavelengths and intensity levels is very low. See also[edit] Gold nanostars deliver drugs directly to cancer cell nucleus. While effective at killing cancer cells, chemotherapy is currently a shotgun approach that can also harm healthy cells and cause serious side effects in patients. The ability to deliver drugs directly into cancer cells would provide a more targeted approach to more effectively treat the disease with lower doses of drugs and less side effects. Researchers at Northwestern University are claiming to be the first to develop gold nanostars that provide a much more precise approach by delivering a drug directly to a cancer cell’s nucleus. The nanoparticles developed at Northewestern are spiky gold nanostars measuring approximately 25 nanometers wide with five to 10 points.
This shape has dual advantages. Not only does it provide a large surface area on which a high concentration of drug molecules can be loaded so less drug would be required than current approaches, but it also changes the shape of the cancer cell nucleus, which improves the effectiveness of the drug release.